edotreotide has been researched along with yttrium in 3 studies
Studies (edotreotide) | Trials (edotreotide) | Recent Studies (post-2010) (edotreotide) | Studies (yttrium) | Trials (yttrium) | Recent Studies (post-2010) (yttrium) |
---|---|---|---|---|---|
206 | 34 | 86 | 3,385 | 166 | 1,626 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bernard, BF; Breeman, WA; de Jong, M; Krenning, EP; Valkema, R | 1 |
Deshmukh, MV; Gemmecker, G; Kessler, H; Kühlewein, A; Mäcke, H; Schmitt, J; Voll, G | 1 |
Angelini, C; Caprotti, R; Crippa, S; Mussi, C; Sartori, P; Uggeri, F | 1 |
3 other study(ies) available for edotreotide and yttrium
Article | Year |
---|---|
Combination radionuclide therapy using 177Lu- and 90Y-labeled somatostatin analogs.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Humans; Lutetium; Male; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Rats; Rats, Inbred Lew; Somatostatin; Survival Analysis; Treatment Outcome; Yttrium | 2005 |
NMR studies reveal structural differences between the gallium and yttrium complexes of DOTA-D-Phe1-Tyr3-octreotide.
Topics: Gallium; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Molecular Structure; Octreotide; Organometallic Compounds; Stereoisomerism; Yttrium | 2005 |
Palliative management strategies of advanced gastrointestinal carcinoid neoplasms.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoid Tumor; Female; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Male; Middle Aged; Octreotide; Palliative Care; Radiopharmaceuticals; Yttrium | 2005 |